secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001493152-24-030671
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus raises ~$3M in registered direct offering and warrant private placement
--------------------------------------------------------------------------------

- Gross proceeds ~$3.0M from sale of 1,643,837 shares and warrants to purchase same number of shares.
- Combined purchase price $1.825 per share and warrant; warrant exercise price $1.70, 5-year term.
- CEO participating, purchasing 84,932 shares and warrants on same terms.
- Closing expected August 8, 2024; net proceeds for R&D and working capital.
- Paulson Investment Company acted as placement agent with 9% cash fee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315224030671/0001493152-24-030671-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315224030671/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-030671

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer